Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.03-31

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623586280?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-03-31 19:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623586280","market":"hk","top_or_hot":-1,"title":"Exploring Three High Growth Tech Stocks In The US Market","media":"Simply Wall St.","content":"<div>\n<p>Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/exploring-three-high-growth-tech-stocks-in-the-us-market-11\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exploring Three High Growth Tech Stocks In The US Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExploring Three High Growth Tech Stocks In The US Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-31 19:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/exploring-three-high-growth-tech-stocks-in-the-us-market-11><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/exploring-three-high-growth-tech-stocks-in-the-us-market-11\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FIVN","symbol_name":"Five9 Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/exploring-three-high-growth-tech-stocks-in-the-us-market-11","article_id":"2623586280","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/exploring-three-high-growth-tech-stocks-in-the-us-market-11","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623586280","pubTimestamp":1774955317,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health that can capitalize on long-term trends despite short-term fluctuations.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"FIVN":"Five9 Inc","BK4139":"生物科技","KRYS":"Krystal Biotech Inc.","VCEL":"Vericel Corporation","BK4023":"应用软件"},"translate_title":"探索美国市场三只高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VCEL":1,"KRYS":1,"FIVN":1},"content_text":"Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health that can capitalize on long-term trends despite short-term fluctuations.AdvertisementTop 10 High Growth Tech Companies In The United StatesNameRevenue GrowthEarnings GrowthGrowth RatingMarker Therapeutics61.33%65.71%★★★★★★Palantir Technologies27.02%31.25%★★★★★★Sandisk30.23%46.19%★★★★★★Reddit22.20%27.96%★★★★★★Gorilla Technology Group54.35%95.02%★★★★★☆Tenaya Therapeutics58.52%60.10%★★★★★☆Zscaler15.93%48.88%★★★★★☆Procore Technologies12.08%99.98%★★★★★☆Duos Technologies Group53.76%155.11%★★★★★☆KVH Industries25.44%135.75%★★★★★☆Click here to see the full list of 73 stocks from our US High Growth Tech and AI Stocks screener.Below we spotlight a couple of our favorites from our exclusive screener.Five9 (FIVN)Simply Wall St Growth Rating: ★★★★☆☆Overview: Five9, Inc. offers intelligent cloud software solutions for contact centers globally and has a market capitalization of approximately $1.10 billion.Operations: The company generates revenue primarily from its Internet Software & Services segment, totaling $1.15 billion.Five9's strategic alliance with Aspect, enhancing real-time customer engagement through advanced forecasting and workforce optimization, underscores its commitment to leveraging AI and cloud technologies for operational efficiency. This partnership is poised to drive significant value by integrating historical and live interaction data into workforce management platforms, optimizing staffing needs against customer demand fluctuations. With a robust annual revenue growth of 8.2% and an impressive turnaround to a net income of $39.42 million from a previous year's loss, Five9 demonstrates solid financial improvement. Moreover, the company's R&D focus remains strong as it collaborates with tech giants like Google Cloud to innovate in enterprise customer experience solutions, ensuring it stays at the forefront of the high-demand cloud-based contact center market.Navigate through the intricacies of Five9 with our comprehensive health report here.Examine Five9's past performance report to understand how it has performed in the past.FIVN Earnings and Revenue Growth as at Mar 2026Vericel (VCEL)Simply Wall St Growth Rating: ★★★★☆☆Overview: Vericel Corporation is a commercial-stage biopharmaceutical company focused on the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America, with a market cap of approximately $1.49 billion.Operations: Vericel generates revenue primarily from its biotechnology segment, amounting to $276.26 million. The company operates in the sports medicine and severe burn care markets across North America.Vericel has demonstrated robust growth with a 59.4% increase in earnings over the past year, outpacing the biotech industry's 40.2% average, signaling strong operational performance and market acceptance. This growth trajectory is supported by significant R&D investments aimed at expanding its product lines and enhancing existing offerings. Recently, FDA approval for commercial manufacturing of MACI at its new facility marks a strategic milestone, enabling increased capacity and potential international expansion. With anticipated revenue growth of 14.7% annually and earnings expected to surge by 32.7% per year, Vericel is strategically positioned to capitalize on advanced therapies in cartilage repair amidst growing global demand.Delve into the full analysis health report here for a deeper understanding of Vericel.Evaluate Vericel's historical performance by accessing our past performance report.VCEL Earnings and Revenue Growth as at Mar 2026Krystal Biotech (KRYS)Simply Wall St Growth Rating: ★★★★★☆Overview: Krystal Biotech, Inc. is a commercial-stage biotechnology company that focuses on discovering, developing, manufacturing, and commercializing genetic medicines to address diseases with high unmet medical needs in the United States, with a market cap of approximately $7.17 billion.Operations: Krystal Biotech focuses on genetic medicines, generating $389.13 million in revenue from treating diseases with high unmet medical needs in the U.S.Krystal Biotech's recent achievements and strategic milestones underscore its robust position in the biotech sector. In 2025, the company reported a substantial increase in net income to $204.83 million, up from $89.16 million the previous year, highlighting a remarkable earnings growth of 129.7%. This performance is bolstered by significant R&D investments which have facilitated innovations like KB707 for NSCLC treatment, receiving FDA's RMAT designation for accelerated development pathways. With revenue and earnings forecasted to grow annually at 24.3% and 28.9% respectively, Krystal is well-positioned to leverage advanced gene therapies addressing critical medical needs.Click here to discover the nuances of Krystal Biotech with our detailed analytical health report.Explore historical data to track Krystal Biotech's performance over time in our Past section.KRYS Revenue and Expenses Breakdown as at Mar 2026Taking AdvantageUnlock our comprehensive list of 73 US High Growth Tech and AI Stocks by clicking here.Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.Want To Explore Some Alternatives?Explore high-performing small cap companies that haven't yet garnered significant analyst attention.Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.Find companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623586280","isCrawlerRequest":true}